Bispecific killer engager for targeted depletion of PD-1 positive lymphocytes: A new avenue for autoimmune disease treatment.

Acta Pharm Sin B · 2025 · PMC12069113 · PMID 40370541

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

For the PD-1 + Raji cells, there was a clear trend of decreasing absorbance values with increasing concentrations of PD-1 BiKE.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.